Omidenepag Isopropyl

Overview

Omidenepag Isopropyl is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4297666).

API suppliers (1)

Suppliers of Omidenepag Isopropyl evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Ube CorporationJapan1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Omidenepag Isopropyl expires 16 Jul 2039 and exclusivity 22 Sept 2027. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

propan-2-yl 2-[[6-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]-2-pyridinyl]amino]acetate

Canonical SMILES

CC(C)OC(=O)CNC1=CC=CC(=N1)CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4

InChIKey

VIQCWEGEHRBLAC-UHFFFAOYSA-N